Varsha Srivastava

Varsha Srivastava, PhD, currently serves as a Regulatory QI and Compliance Specialist at the University of Maryland since October 2022, after previously holding the position of Regulatory Affairs Specialist at FDA MAP from January 2021 to September 2022, where responsibilities included document development and project management. Prior experience included a postdoctoral researcher role at the University of Maryland from 2010 to 2012, focusing on the regulation of interferon-regulated gene expression in tumorogenesis, along with a research internship at Hindustan Lever Research Centre in 2005, contributing to the development of skin care products. Varsha holds a PhD in Microbiology and Immunology from Jawaharlal Nehru University and several certifications in regulatory affairs and clinical research from institutions such as RAPS Online University and Duke University School of Medicine.